ILLUCCIX, a radioactive diagnostic agent, is supplied as a sterile, multiple -dose kit for the preparation of Gallium Ga 68 G ozetotide Injection for intravenous use.

Read about the availability of Illuccix® kits for on-demand production of ⁶⁸Ga-PSMA-11 doses. Please see Important Safety Information and Prescribing Information.

ILLUCCIX, a radioactive diagnostic agent, is supplied as a sterile, multiple-dose kit for the preparation of Gallium Ga 68 Gozetotide Injection for intravenous use.

View the established clinical efficacy for Illuccix® across prostate cancer stages demonstrated in pivotal trials with ⁶⁸Ga-PSMA-11. Please see Important Safety Information and Prescribing Information.

Discover Illuccix® for patients with suspected prostate cancer metastasis who are candidates for initial definitive therapy, or suspected recurrence based on elevated serum prostate-specific antigen (PSA) …

Learn about our Illuccix® Reimbursement Support program, find codes for submitting claims, and how to obtain prior authorization. Please see Important Safety Information and Prescribing Information.

After reconstitution and radiolabeling of ILLUCCIX, the vial contains Gallium Ga 68 Gozetotide Injection. Handle Gallium Ga 68 Gozetotide Injection with appropriate safety measures to minimize radiation …

ILLUCCIX, after radiolabeling with Ga 68, is a radioactive diagnostic agent indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men …

View PSMA PET patient scans with Illuccix at initial staging, BCR, and BCR with uEXPLORER. Please see Important Safety Information and Prescribing Information.

Learn about imaging workflow enhancements with Illuccix and SubtlePET™. Please see Important Safety Information and Prescribing Information.